A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
Findings in Developmental Cell show that expression of an early developmental gene prevents the immune system from identifying and attacking cancer cells